Specimen Collection for Fetal Aneuploidy Test Development
This study is collecting blood samples from pregnant women to help develop a new, non-invasive test for Down Syndrome and other fetal aneuploidies (having an abnormal number of chromosomes). You may be able to join if you are pregnant between 10 and 22 weeks, are 18 or older, and have an increased risk for fetal aneuploidy. You must also be willing to have a CVS (chorionic villus sampling) or amniocentesis procedure and share the genetic results. The study aims to compare the results from the new blood test with the results from these invasive procedures to see how well the new test works. The current recruitment status is unclear, and the study plans to enroll 2000 participants.
- Study design
- This is an observational study, meaning researchers will collect information without giving any specific intervention. It plans to include 2000 pregnant women.
- What's involved
- You would need to provide a blood sample and agree to undergo a CVS and/or amniocentesis procedure. You would also need to provide the genetic results from that procedure.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
At a glance
A primary outcome measure isn't published for this study.
Conditions
Where it's being run
14 sites across 9 statesStudy leadership
- Daniel Grosu, MD · STUDY_DIRECTOR · Sequenom, Inc.
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.